ABSTRACT
Moya Moya disease is a rare cause of stroke in adults, and is a rarity secondary to hepatitis C virus infection (HCV) and cryoglobulinemia (CG). We report such a rare association in a young patient who presented with intracerebral hemorrhage.
Subject(s)
Adult , Cerebral Hemorrhage, Traumatic/etiology , Cryoglobulinemia/complications , Hepatitis C/complications , Humans , Male , Moyamoya Disease/complications , Stroke/etiologyABSTRACT
Thrombocytosis is a common clinical condition. Drugs used for thrombocytosis are hydroxy urea, alkylating agents and interferon alpha. We are reporting a case of chronic myeloid leukemia with thrombocytosis who did not respond to hydroxy urea but was controlled with the addition of a new drug anagrelide. Anagrelide is a platelet reducing agent with no serious side effects. It may be the main weapon against thrombocytosis associated with chronic myeloid leukaemia (CML) and essential thrombocytosis in the coming years.